Antimicrobial resistance is an old and silent pandemic. Resistant organisms emerge in
parallel with new antibiotics, leading to a major global public health crisis over time …

Highlights•Adjuvants potentiate existing antibiotics or combat mechanisms of
resistance.•Probes enable the identification of enzymes that modify tuberculosis …

Despite colossal achievements in antibiotic therapy in recent decades, drug-resistant
pathogens have remained a leading cause of death and economic loss globally. One such …

Pseudomonas aeruginosa (P. aeruginosa) poses a grave clinical challenge due to its
multidrug resistance (MDR) phenotype, leading to severe and life-threatening infections …

The problematic combination of a rising prevalence of skin and soft tissue infections and the
growing rate of life-threatening antibiotic resistant infections presents an urgent, unmet need …

Antimicrobial resistance presents us with a potential global crisis as it undermines the
abilities of conventional antibiotics to combat pathogenic microbes. The history of …

NorA, an extensively studied efflux pump in Staphylococcus aureus, has been connected to
fluoroquinolone, antiseptic, and disinfection resistance. Several studies have also …

The global spread of multidrug-resistant (MDR) bacteria increases the demand for the
discovery of new antibiotics and adjuvants. Phenylalanine-arginine β-naphthylamide …

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that causes life-
threatening and persistent infections in immunocompromised patients. It is the culprit behind …

Wound infections with antibiotic-resistant bacteria, particularly the Gram-negative strains,
pose a substantial health risk for patients with limited treatment options. Recently topical …